Annexon (ANNX) Minority Interest (2019 - 2020)
Annexon's (ANNX) quarterly Minority Interest came in at $235.1 million in Q2 2020, up 129.06% year-on-year from $102.6 million in Q3 2019, and up 62.93% quarter-over-quarter from $144.3 million in Q1 2020.
Annexon (ANNX) Minority Interest (2019 - 2020) Analysis & Trends
Annexon's Minority Interest history runs 2 years deep, the most recent figure standing at $235.1 million for Q2 2020.
- On a quarterly basis, Minority Interest rose 129.06% year-over-year to $235.1 million in Q2 2020; TTM through Jun 2020 was $235.1 million, a 129.06% increase from a year earlier, with the FY2019 full-year figure at $144.0 million, changed N/A from the prior year.
- Minority Interest advanced to $235.1 million in Q2 2020 per ANNX's latest filing, from $144.3 million in the prior quarter.
- Across five years, Minority Interest topped out at $235.1 million in Q2 2020 and bottomed at $10.8 million in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Annexon | 1.03 Bn | 804.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 235.05 Mn |
| Mar 31, 2020 | 144.26 Mn |
| Dec 31, 2019 | 143.98 Mn |
| Sep 30, 2019 | 10.81 Mn |
| Jun 30, 2019 | 102.62 Mn |